Clinical trial
Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or…
NCT00019513 · National Institutes of Health Clinical Center (CC), NIH · Completed
Key facts
| NCT number | NCT00019513 |
|---|---|
| Title | Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or Lymphomas |
| Official title | A Phase I Study of Weekly Gemcitabine in Combination With Infusional 5-Fluorouracil and Oral Calcium Leucovorin in Adult Cancer Patients |
| Lead sponsor | National Institutes of Health Clinical Center (CC), NIH |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Colorectal Cancer, Esophageal Cancer, Extrahepatic Bile Duct Cancer, Gallbladder Cancer, Liver Cancer, Lung Cancer, Lymphoma, Pancreatic Cancer, Small Intestine Cancer, Unspecified Adult Solid Tumor and 1 more |
| Intervention type | Drug |
| Interventions | fluorouracil, gemcitabine hydrochloride, leucovorin calcium |
| Enrollment | 108 |
| Start date | Aug 1, 1998 |
| Completion | Jun 1, 2004 |
| First posted | Jan 27, 2003 |
| Last update posted | Mar 23, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: